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Email: jonathanweitzman@hotmail.com DiGeorge syndrome (DGS; also known as velo-cardio-facial syndrome is associated with hemizygous deletion of a region of human chromosome 22q11, causing a range of abnormalities including cardiovascular defects, hypoplasia of the thymus and parathyroid gland, and craniofacial abnormalities. , 27:286-291) , show that TBX1 haploinsufficiency in mice causes cardiovascular defects and anomalies of the heart outflow tract that resemble the human syndrome. Furthermore, TBX1-/-mice also display thymus and parathyroid abnormalities, as seen in DGS patients. TBX1 is the first dosage-sensitive gene to be identified in the deleted 22q11 region. It remains to be established whether TBX1 mutation alone accounts for DiGeorge syndrome, and whether human patients differ from the mouse models in their sensitivity to TBX1haploinsufficiency.
